2.0000
0.0000
(0.00%)
As of January 29 at 3:00:00 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in AUD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 5 | 5 |
| Avg. Estimate | 2.39M | 2.49M | 91.45M | 601.66M |
| Low Estimate | 2.39M | 2.49M | 9.48M | 47.4M |
| High Estimate | 2.39M | 2.49M | 358.36M | 2.6B |
| Year Ago Sales | -- | 5.22M | 8.7M | 91.45M |
| Sales Growth (year/est) | -- | -52.31% | 951.14% | 557.90% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MEOBF | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
ENZN Enzon Pharmaceuticals, Inc.
0.1500
+15.38%
CRNX Crinetics Pharmaceuticals, Inc.
40.15
-0.27%
PALI Palisade Bio, Inc.
1.4073
-1.59%
TECH Bio-Techne Corporation
73.31
+0.76%
ONC BeiGene, Ltd.
226.86
-0.01%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7100
-1.15%
IMRX Immuneering Corporation
1.9900
+2.58%
VERA Vera Therapeutics, Inc.
37.77
+0.77%
MURA Mural Oncology plc
3.8100
+1.08%
QURE uniQure N.V.
15.71
-0.51%